We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Endometrial Sampling (Pipelle)in IVF Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Sheba Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00411021
First Posted: December 13, 2006
Last Update Posted: December 13, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose
A prospective cross-over randomized study aimed to test the hypothesis that local injury of the endometrium increases the implantation rate in the successive cycle. Seventy IVF patients will be randomly selected to undergo either endometrial biopsies or minimal cervical scratch on days 8-10 and 21-23 of their cycle, preceding the IVF treatment. If not pregnant, the women will continue for another IVF cycle, preceded by endometrial or cervical scratch complimentary to their procedure in the first cycle. The main major outcomes will include pregnancy rate, implantation rate, endometrial thickness, abortion rate, live births and embryo quality.

Condition Intervention
Infertility Procedure: Pipelle (Endometrial Sampling)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Endometrial Sampling (Pipelle)in IVF Patients

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 70
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women undergoing IVF treatment
  • Repeated Implantation failure

Exclusion Criteria:

  • PID or suspected PID
  • Undiagnosed Irregular Bleeding
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00411021


Contacts
Contact: Micha Baum, MD baumdr@zahav.net.il

Locations
Israel
IVF Unit, Sheba Medical Center Recruiting
Ramat-Gan, Israel, 52621
Contact: Micha Baum, MD       baumdr@zahav.net.il   
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Micha Baum, MD Sheba Medical Center, Israel
  More Information

ClinicalTrials.gov Identifier: NCT00411021     History of Changes
Other Study ID Numbers: SHEBA-05-3674-MB-CTIL
First Submitted: December 12, 2006
First Posted: December 13, 2006
Last Update Posted: December 13, 2006
Last Verified: December 2006

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female